Profiling of Potential Postmarket Risk Tracking and Pharmacovigilance Data for Avacopan

Key Points

• Safety monitoring indicates potential risks associated with Avacopan, emphasizing the importance of robust pharmacovigilance efforts.
• Data analytics utilized to identify adverse events and patterns in postmarket reports of Avacopan use, with insights on specific patient demographics.
• Innovative pharmacovigilance frameworks assessed for their effectiveness in tracking postmarket risk in relation to Avacopan treatment.
• Support for continuous safety evaluations presents a vital approach to minimize adverse events in patients using Avacopan.